Cabozantinib Laurylsulfate Patent Expiration
Cabozantinib Laurylsulfate was first introduced by Handa Oncology Llc
Cabozantinib Laurylsulfate Patents
Given below is the list of patents protecting Cabozantinib Laurylsulfate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Omcazio | US12415784 | Cabozantinib Compositions And Methods Of Use | Jan 30, 2044 | Handa Oncol |
| Omcazio | US12516025 | Cabozantinib Compositions And Methods Of Use | Jan 30, 2044 | Handa Oncol |
| Omcazio | US12552567 | Method For Packaging Articles In Boxes And Packaging Device Operating According To Such A Method | Jan 30, 2044 | Handa Oncol |
| Omcazio | US12552749 | Cabozantinib Compositions And Methods Of Use | Jan 30, 2044 | Handa Oncol |
| Omcazio | US12741938 | Cabozantinib Compositions And Methods Of Use | Jan 30, 2044 | Handa Oncol |
| Omcazio | US12064430 | Kinase Inhibitor Salts And Compositions Thereof | Jun 13, 2039 | Handa Oncol |
Cabozantinib Laurylsulfate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List